Michelle Marshall

Histoire de la candidature

"I am proud to nominate Michelle for the Momentum Award because she exemplifies what it means to lead meaningful change in home‑based care and to expand access without compromising quality, safety, or outcomes. Michelle has been instrumental in the successful launch and growth of Palmetto Infusion’s Specialty Home Infusion program. At a time when healthcare is rapidly shifting toward alternative sites of care, she helped turn strategy into reality by building the operational and clinical foundation required to safely deliver complex infusion therapies in the home. Her work has directly enabled more patients to receive high‑acuity care in a cost‑effective, convenient setting while maintaining the clinical rigor traditionally associated with institutional environments. What makes Michelle’s impact particularly compelling is her ability to lead change across multiple dimensions at once. She has collaborated closely with stakeholders across clinical, intake, sales, operations, and technology teams to ensure processes were clearly defined, communicated, and operationalized. These efforts reduced ambiguity, improved coordination, and removed barriers that often delay or limit patient access to home infusion services. Michelle partnered with the sales team to create reporting processes that provide transparency and reassurance to referring providers, ensuring they know when patients have received their medication and that therapy is progressing as intended. In parallel, she worked hand in hand with the intake department to ensure all documentation required for payer authorization is obtained efficiently, helping prevent avoidable delays that can interrupt care. She has also contributed meaningfully to Palmetto’s technology evolution. Michelle has participated in integration planning for the organization’s new EMR and is actively involved as Palmetto continues implementing the AlayaCare patient management system and its Marketplace capabilities. Her involvement has focused on ensuring these tools support real‑world workflows, improve visibility across the care team, and ultimately enable scalable growth that expands access to home‑based care across multiple states. Perhaps most importantly, Michelle has never lost sight of the patient experience. She conducts welcome calls with specialty infusion patients, taking time to explain the home infusion process, set expectations, and build trust during what is often a stressful transition in care. She completes environmental assessments to ensure homes are appropriate for infusion therapy, reinforcing both safety and confidence in the alternative site of care model. Across her territory, Michelle coordinates care with contracted agencies spanning multiple states to ensure patients receive the therapies they need, when they need them. Her oversight promotes compliance, continuity, and positive clinical outcomes, even in complex and resource‑challenged environments. Michelle is a true solutions‑driven leader. She consistently looks beyond obstacles to find practical, patient‑centered ways to improve access, simplify processes, and elevate care delivery. Through her leadership, she has helped shape a specialty home infusion program that is scalable, clinically sound, and deeply aligned with the needs of patients, providers, and caregivers. For her role in expanding access to high‑quality home‑based care, leading operational and technological change, and setting a higher standard for specialty infusion services in the home, Michelle is exceptionally deserving of the Momentum Award."